Globus Medical, which has a market cap of $11.9bn, will buy all Nevro ... stimulator systems, for example, gained access to a wider market after winning FDA approval for non-surgical back pain ...

life-changing solutions for the treatment of chronic pain. “We are excited to begin the journey of accelerating market penetration of Nevro’s differentiated high-frequency technology and ...